Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype |diabetes
Sentences 529
PubMedID- 21875885 We evaluated the differences between low and high chocolate consumption on outcomes such as diabetes, incidence of cardiovascular disease, cardiovascular mortality, coronary heart disease, incidence of stroke, and deaths from stroke.
PubMedID- 25526571 Key words: vitamin d, diabetes mellitus, deficiency of vitamin d, cancer, cardiovascular diseases, muscle physiology.
PubMedID- 22116350 The number of epidemiological studies assessing the relationship between ppg and microvascular or cardiovascular disease in subjects with diabetes is surprisingly scarce.
PubMedID- 21080957 Therefore, based on the findings from the present study and the accumulating body of clinical evidence with exenatide, therapy with glp-1 receptor agonists may represent a promising approach for the treatment of patients with chf or cardiovascular disease associated with type 2 diabetes, supporting the need for further research in this field.
PubMedID- 23251757 Reduction of low-density lipoprotein cholesterol (ldl-c) with statins is highly effective in reducing cardiovascular disease in patients with and without diabetes, but leaves unaddressed a sizeable residual vascular risk (rvr), which is rarely quantified in routine clinical practice.
PubMedID- 19664902 Changes in certification of diabetes with cardiovascular diseases increased reported diabetes mortality in australia and the united states.
PubMedID- 21934489 Although perturbations of haemostatic markers have been shown to be associated with macrovascular disease in patients with type 2 diabetes, it is unclear whether these are primarily due to endothelial dysfunction or a result of inflammation.
PubMedID- 22247785 There is solid evidence for an important role for the microcirculation as a possible link between the cardiometabolic risk factors insulin resistance and hypertension, conditions that may further develop into diabetes with subsequent cardiovascular disease.
PubMedID- 25661661 Exclusion of these is likely to underestimate the benefit from any preventative intervention and thus underestimate the cost-effectiveness (that is, overestimate the icer), particularly in the longer term as patients avoid cardiovascular disease and live with diabetes long enough to develop microvascular complications.
PubMedID- 21297971 Endothelial dysfunction is an important defect that contributes to erectile dysfunction and vascular disease in diabetes and is associated with insulin resistance [18].
PubMedID- 21475396 A general limitation of all perfusion techniques may arise from the presence of microvascular disease in diabetes, hypertension, and hypercholesterolemia.
PubMedID- 25279360 Introduction: diabetes mellitus is associated with cardiovascular disease.
PubMedID- 26313785 A study by tobias et al20 reported results similar to ours with a j-shaped association across bmi categories for all-cause mortality in participants with incident diabetes who were free of cardiovascular disease and cancer at the time of a diagnosis of diabetes.
PubMedID- 21515838 In brief, we enrolled 2,539 patients, aged between 30 and 85 years, with type 2 diabetes and no history of cardiovascular disease.
PubMedID- 26555141 Associations were examined after adjusting for individual demographic (age, gender, ethnicity), medical (hypertension, diabetes, hyperlipidaemia, history of cardiovascular disease [cvd]) and life-style (alcohol and smoking status) risk factors.
PubMedID- 21943205 However, applying a score with a required 9 input variables (i.e., age, female, anemia, hypertension, diabetes, history of cardiovascular disease, congestive heart failure, peripheral vascular disease, and proteinuria) in clinical practice might not be as simple as suggested.
PubMedID- 21270271 Patients with type 1 diabetes have increased levels of subclinical cardiovascular disease, as measured by carotid intima-media thickness (imt), a measure of atherosclerosis.
PubMedID- 20587725 Those with diabetes had no history of hypertension or macrovascular disease, and microvascular disease was excluded.
PubMedID- 24271693 Results suggested that cardiovascular disease patients with diabetes, particularly males, experience high rates of depression, suicide ideation, and posttraumatic stress symptoms.
PubMedID- 26019685 Age, race, primary renal disease, treatment modality, diabetes, history of cardiovascular disease or smoking, and hemoglobin, albumin, blood creatinine, and blood calcium levels were associated with prognosis.
PubMedID- 22860108 Gender, diabetes, family history of cardiovascular disease, smoking and sedentary habitus, blood pressure, and biochemical variables did not distinguish survivors and non-survivors.
PubMedID- 21264179 The pathophysiology of vascular disease in diabetes involves abnormal function of the vascular endothelial and smooth muscle cells (smc) as well as platelets.
PubMedID- 22942227 Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
PubMedID- 24533664 Among individuals with established diabetes, risk of cardiovascular disease and mortality can be reduced by intensive treatment of multiple risk factors, including blood pressure, cholesterol and glucose, although there remains some uncertainty about the merits of tight glycaemic control.
PubMedID- 22111049 However, the relationships between dpn and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes have not been fully investigated.
PubMedID- 22402944 To elucidate the pathogenesis of macrovascular disease in diabetes, animal models are widely used.
PubMedID- 24977070 Patients were excluded for the following reasons: age over 75 or under 55, previous surgery to the index joint, inflammatory arthritis, relevant comorbidity (tumors, diabetes mellitus, history of respiratory disease, cardiovascular disease, mental health problems, musculoskeletal system diseases, previous endocrinological diagnosis) or refusal to answer to the questionnaires.
PubMedID- 26202844 Postprandial bgls have been shown to increase the risk factors for cardiovascular disease in people with type 1 diabetes [13, 14].
PubMedID- 23751310 Metformin, the first-line medication for diabetes, has the superiority of reducing risk of macrovascular diseases, all-cause mortality and even possibly cancers.

Page: 1 2 3 4 5 6 7 8 9 10 11